Vocalis Gel
System, Vocal Cord Medialization. 510(k) K081815, from Cytophil, Inc. (Whitefish Bay, WI). Product code MIX, class 2.
As of Nov 21, 2026, K081815 is an FDA 510(k) held by Cytophil, Inc., substantially equivalent on Jan 5, 2009 after 193 days, with no recalls tied to it in FDA's recall database.
- Review time: 193 days
- Recalls: 0
Vocalis Gel is indicated for vocal fold medialization and vocal fold insufficiency that may be improved by injection of a soft tissue bulking agent. Vocalis Gel injection augments the size of the displaced or deformed vocal fold so that it may meet the opposing fold at the midline for improved phonation.
- Modification To VF Gel PlusK080956 · Coapt Systems, Inc. · Apr 25, 2008
- Coaptite Laryngeal Augmentation System 1CC & O.5CC, Models 0008021-1, 0008022-1K013243 · Bioform, Inc. · Jan 9, 2002
- Radiesse Laryngeal ImplantK070090 · Bioform Medical, Inc. · Mar 1, 2007
- VF Gel PlusK071663 · Coapt Systems, Inc. · Feb 15, 2008
- Silk Voice (SMI-04)K240919 · Sofregen Medical · May 3, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 26, 2008
- Review panel
- Ear, Nose, Throat
- Regulation
- 21 CFR 874.3620
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files